Active GLP-1 levels were determined by using an active GLP-1 ELISA kit (EGLP-35K, Merck/millipore) according to the manufacturers instructions
Haematologica
By removing the psychological and practical barriers associated with injectable treatments, oral GLP-1s have the potential to reposition obesity care as a routine, chronic intervention rather than a specialist-led, escalation therapy
Build Stronger GLP-1 Cases with Complete Medical Evidence LlamaLab retrieves records from all provider types in 24 hourswith AI that identifies missed treating physicians and flags the diagnostic tests courts require
Data were analysed using one-way ANOVA with Bonferroni post hoc multiple-comparison test ( d , e , h ), two-way repeated-measures ANOVA ( a , c , f , g ), or Kruskall-Wallis test with uncorrected Dunnss test ( i )